Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cronos Group Inc (CRON) vs Kroger Co (KR) Price & Performance

Cronos Group IncTrade

Price performance (Past 24H)

Key statistics

Cronos Group Inc vs Kroger Co — how do they compare? Cronos Group Inc trades at $3.23 (market cap $1.20B), while Kroger Co trades at $61.28 (market cap $34.99B). The key difference: Kroger Co is far larger — about 29.2× Cronos Group Inc's market cap, and Kroger Co pays a 2.63% dividend while Cronos Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cronos Group Inc for 22 Days and Kroger Co for 108 Days on average.

CRONKR
Market Cap
$1.20B$34.99B
Volume
450,3878,938,607
Sector
HealthConsumer Staples
52-Week High
$3.55$75.60
52-Week Low
$2.30$55.53
Typical Hold Time
22 Days108 Days
Enterprise Value
$401.73M$56.41B
Dividend Yield
—2.63%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cronos Group Inc

CRON trades at $3.22, down 1.98% on the day, amid a bearish technical signal. The company reported mixed quarterly earnings but achieved record revenue and gross profit in Q2 2026, with net income turning positive. Recent investor day highlighted international expansion and cash flow focus. Valuation ratios show a P/E of 17.11 and P/S of 6.91, with strong net income margin of 39.08% projected for 2026.

Outlook is cautiously optimistic, driven by revenue growth and profitability improvements, but risks include cash flow volatility and competitive pressures. Analyst consensus is mixed with 60% hold rating. The stock's near-term performance hinges on execution of expansion plans and sustained earnings momentum.

Kroger Co

Kroger (KR) trades at $61.41, up 5.14% today, with a bullish technical signal from moving averages. The stock shows strong fundamentals with $147.12B in revenue, though net margins remain thin at 0.73%. Recent earnings show mixed results with Q2 2026 beating expectations but Q1 2026 missing. The company maintains positive cash flow generation and continues dividend payments while facing competitive pressures in the grocery sector.

Kroger presents a balanced investment case with attractive valuation metrics (P/S 0.25) and analyst consensus pointing to 15% upside to $70.62 target. However, risks include integration challenges from acquisitions, margin pressure from price competition, and softer 2026 sales guidance. The stock offers value characteristics with dividend yield support amid ongoing digital transformation efforts.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

CRON

No sentiment data available yet.

KR
76% Buy24% Sell
Avg holding period · 108 Days

Top news

Latest headlines on both assets

About Cronos Group Inc

Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.

Read more on CRON →

About Kroger Co

Kroger is the leading American grocer, with 2,726 supermarkets operating under several banners throughout the country as of the end of fiscal 2021. Around 83% of stores have pharmacies, while nearly 60% also sell fuel. The company also operates roughly 120 fine jewelry stores. Kroger features a leading private-label offering and manufactures around 30% of its own-brand units (and more than 40% of its grocery own-label assortment) itself, in 33 food production plants nationwide. Kroger is a top-two grocer in most of its major markets (as of early 2021, according to company data). Virtually all of Kroger's sales come from the United States.

Read more on KR →